GRAIL, Inc. is a biotechnology company that develops tests for detecting cancer early. Its lobbying filings show it focuses on health and Medicare/Medicaid issues, including support for the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842 / S. 339). It has reported hiring Ballard Spahr LLP and spent about $80,000 across four filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
MARIA TRIPPLAAR
The latest disclosures for this client.
BALLARD SPAHR LLP
Q2BALLARD SPAHR LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BALLARD SPAHR LLP
TIMOTHY W JENKINS
BALLARD SPAHR LLP
BALLARD SPAHR LLP
Q4BALLARD SPAHR LLP
Q3BALLARD SPAHR LLP
Q2BALLARD SPAHR LLP
Q1